Replies to post #133690 on Biotech Values

[zipjet]

MNTA’s out-of-pocket costs for process development within the BAX partnership will be fully or substantially covered by the $91M in technical milestones payable by BAX, according to today’s CC.

Right. As I said, the "bet" is that the costs will be "returned".

But the expenses are real and certain, while the reimbursement via milestones is aspirational and uncertain.

:-)

ij